Centessa Pharmaceuticals Cash Flow Statement (2020-2026) | CNTA

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-41.45M-40.16M-60.77M-54.50M-64.66M-53.92M-43.17M-50.71M-24.89M-38.65M-36.84M-38.05M-43.82M-42.57M-111.33M-26.14M-50.34M-54.89M-66.16M-79.24M
Depreciation and Depletion (Quarter)
0.01M0.02M0.03M0.03M0.04M0.04M0.04M0.08M0.09M0.09M0.09M0.08M0.08M0.05M
Share-based Compensation (Quarter)
3.23M4.13M4.76M5.72M5.60M7.03M6.62M7.19M7.21M7.56M7.43M8.15M8.61M8.45M8.33M7.88M7.95M7.19M7.94M10.56M
Deferred Taxes (Quarter)
-0.14M-2.77M-23.49M-2.89M-0.15M0.43M0.57M1.25M0.40M0.99M1.03M0.26M0.23M0.83M
Gains from Investment Securities (Quarter)
-0.21M9.71M2.76M0.97M1.59M4.39M0.10M0.12M0.18M3.65M
Cash from Operations (Quarter)
-33.88M-33.17M-56.43M-50.02M-59.88M-39.09M-51.56M-47.84M-44.06M-37.39M-31.05M-37.29M-40.58M-21.39M-42.80M-57.25M-22.45M-58.31M-55.81M-72.22M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
2.08M0.05M0.11M-0.45M-0.81M
Amortization of Deferred Charges (Quarter)
0.31M0.29M0.27M0.28M0.34M
Depreciation & Amortization (CF) (Quarter)
0.01M0.01M0.01M0.03M0.03M0.04M0.04M0.09M0.24M0.24M0.25M0.24M0.24M0.24M0.23M0.22M0.23M0.24M0.24M0.24M
Change in Working Capital
Change in Account Payables (Quarter)
-4.39M3.37M-1.37M-1.22M1.84M3.13M2.60M-1.81M-1.58M0.08M0.59M-4.25M-2.18M1.71M0.14M-2.10M0.18M3.28M-1.31M3.26M
Change in Accured Expenses (Quarter)
3.71M2.93M5.33M2.59M5.37M3.14M-4.83M-9.77M6.78M0.15M2.04M-9.41M3.28M-3.83M32.73M-29.55M2.88M-0.69M12.14M-9.02M
Investing Activities
Capital Expenditures (Quarter)
0.04M0.05M0.06M0.24M0.23M0.02M0.65M0.09M0.01M0.04M0.03M0.03M0.23M0.01M
Acquisitions (Quarter)
-4.60M
Change in Acquisitions & Divestments (Quarter)
86.25M51.83M36.76M65.08M45.00M25.00M75.09M43.23M107.69M95.59M118.25M
Cash from Investing Activities (Quarter)
-0.15M-0.05M-0.06M-0.24M-0.23M-0.02M-0.45M-86.34M-71.10M48.71M-18.27M16.76M-55.46M44.96M25.00M-222.39M-39.95M61.95M-218.13M42.71M
Financing Activities
Other financing activities (Quarter)
-0.31M0.01M-0.26M-0.40M-0.01M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
73.93M
Change in Capital Stock
Shares Issued (Quarter)
343.84M0.34M0.07M0.22M-0.63M0.01M0.18M0.12M0.84M0.80M4.25M5.34M6.11M-2.64M3.56M14.33M34.12M
Shares Repurchased (Quarter)
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)
345.82M-1.99M74.43M0.07M0.07M0.22M0.09M0.01M14.74M6.36M10.49M105.31M245.98M2.96M3.09M1.60M3.44M283.40M30.47M
Exchange Rate Effect (Quarter)
3.35M0.27M-1.67M-0.43M-0.27M-0.44M0.72M0.52M0.38M0.22M-0.50M0.22M-0.12M-1.90M3.03M-1.52M-0.11M-0.50M1.68M0.18M
Change in Cash (Quarter)
315.15M-34.95M16.27M-50.62M-60.30M-39.32M-51.20M-133.66M-114.77M26.28M-43.47M-9.81M9.15M267.65M-11.80M-278.06M-60.91M6.57M11.14M1.13M
Beginning Cash Balance (Quarter)
-0.01M0.26M
Free Cash Flow (Quarter)
-33.91M-33.22M-56.49M-50.26M-60.11M-39.10M-52.22M-47.93M-44.07M-37.44M-31.08M-37.29M-40.58M-21.42M-42.80M-57.25M-22.45M-58.55M-55.82M-72.22M
Net Cash Flow (Quarter)
311.80M-35.21M17.94M-50.18M-60.04M-38.88M-51.92M-134.17M-115.15M26.06M-42.96M-10.03M9.27M269.56M-14.84M-276.55M-60.80M7.07M9.46M0.95M